1[1]Thun MJ,Namboodiri MM,Calle EE.Aspirin use and risk of fatal cancer.Cancer,1993,53:1322-1327.
2[2]Funkhouser EM,Sharp GB.Aspirin and reduced risk of esophageal carcinoma.Cancer,1995,76:1116-1119.
3[3]Langman MJS,Gheng KK,Gilman EA,et al.Effect of anti-inflammatory drug on overall risk of common cancer:case-control study in general practice researsh database.Br Med J,2000,320:1642-1646.
4[4]Li M,Lotan R,Levin B,et al.Aspirin induction of apoptosis in esophageal cancer:a potential for chemoprevention.Cancer Epidemiol Biomarkers Prev,2000,9:545-549.
5[5]Morris C,Armstrong GR,Bigley G,et al.Cyclooxygenase-2 expression in the Barrett metaplasia,dysplasia,adenocarcinoma sequence.Am J Gastroenterol,2001,96:990-996.
6[6]Zimmermann KC,Sarbia M,Weber AA.Cyclooxygenase-2 expression in human esophageal carcinoma.Cancer Res,1999,59:198-204.
7[7]Souza RF,Shewmake K,Beer DG,et al.Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.Cancer Res,2000,60:5767-5772.
8[8]Shirvani VN, Ouatu-Lascar R, Kaur BS, et al.Cyclooxygen-ase-2 expression in Barrett′s esophagus and adenocarcinoma:ex vivo induction by bile salts and acid exposure.Gastroen-terology,2000,118:487-496.
9[9]Morris C,Bigley G,Armstrong G,et al.Expression of cyclooxygenase-2 in Barrett′s esophagus,dysplasia,and adenocarcinoma.Gastroenterology,2000,118:A685.
10[10]Souza R,Shewmake K,Beer D,et al.Selective inhibition of cyclooxygenase-2 inhibts growth,and induces apoptosis in human esophageal adenocarcinoma cells.Gastroenterology,2000,118:A707.
